Literature DB >> 11983287

A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction.

Marián Revilla1, Víctor Obach, Alvaro Cervera, Antonio Dávalos, José Castillo, Angel Chamorro.   

Abstract

Interleukin-6 (IL-6) is a pleiotropic cytokine that plays a central role in the pathogenesis of stroke. A base pair substitution -174G/C in the promoter region of the IL-6 gene regulates IL-6 gene expression. We compared the prevalence of this polymorphism in patients with lacunar stroke and in an age- and sex-matched cohort of asymptomatic controls. Eighty-two patients with lacunar stroke and 82 asymptomatic controls were prospectively assessed and genotyped for the -174G/C polymorphism in the promoter region of the IL-6 gene. Demographics and vascular risk factors were recorded in both groups. A brain computed tomography scan/magnetic resonance imaging confirmed the clinical diagnosis of lacunar stroke in all patients. The prevalence of CC genotype (18.3 vs. 7.3%, P=0.03), and the frequency of C allele (42.7 vs. 31.1%, P=0.03) were statistically significantly higher in patients with lacunar stroke than in asymptomatic controls. Expectedly, patients with lacunar stroke had a higher prevalence of vascular risk factors than asymptomatic controls. A logistic regression model showed that independent variables associated with lacunar stroke included history of hypertension (odds ratio (OR), 7.02; 95% confidence interval (95% CI), 3.11-15.81), diabetes (OR, 5.37; 95% CI, 1.52-8.89), hyperlipidemia (OR, 3.43; 95% CI, 1.04-11.25), smoking (OR, 5.84; 95% CI, 2.15-15.84), and CC genotype of the -174G/C IL-6 gene polymorphism (OR, 4.28; 95% CI, 1.22-15.00). These findings suggest that lacunar stroke might result from genetic susceptibility to inflammation-mediated damage in concert with atherosclerotic risk factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983287     DOI: 10.1016/s0304-3940(02)00169-6

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  28 in total

Review 1.  Inflammatory markers and stroke.

Authors:  Mitchell S V Elkind
Journal:  Curr Cardiol Rep       Date:  2009-01       Impact factor: 2.931

2.  The Levels of Inflammatory Markers in the Treatment of Stroke study (LIMITS): inflammatory biomarkers as risk predictors after lacunar stroke.

Authors:  M S V Elkind; J M Luna; C S Coffey; L A McClure; K M Liu; S Spitalnik; M C Paik; A Roldan; C White; R Hart; O Benavente
Journal:  Int J Stroke       Date:  2010-04       Impact factor: 5.266

3.  The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.

Authors:  L Morgan; J Cooper; H Montgomery; N Kitchen; S E Humphries
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04-28       Impact factor: 10.154

4.  Tumour necrosis factor alpha, ınterleukin 10 and ınterleukin 6 gene polymorphisms of ıschemic stroke patients ın south Marmara region of Turkey.

Authors:  Adile Ozkan; Fatma Sılan; Ahmet Uludağ; Yıldız Degirmenci; Handan Isin Ozisik Karaman
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

5.  C-reactive protein as a prognostic marker after lacunar stroke: levels of inflammatory markers in the treatment of stroke study.

Authors:  Mitchell S V Elkind; Jorge M Luna; Leslie A McClure; Yu Zhang; Christopher S Coffey; Ana Roldan; Oscar H Del Brutto; Edwin Javier Pretell; L Creed Pettigrew; Brett C Meyer; Jorge Tapia; Carole White; Oscar R Benavente
Journal:  Stroke       Date:  2014-02-12       Impact factor: 7.914

6.  Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia.

Authors:  Peter Reismann; Christoph Lichy; Gottfried Rudofsky; Per M Humpert; Just Genius; Tuan-Dong Si; Christof Dörfer; Armin J Grau; Andreas Hamann; Werner Hacke; Peter P Nawroth; Angelika Bierhaus
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

7.  Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Robert C Kaplan; Aileen P McGinn; Alison E Baird; Susan L Hendrix; Charles Kooperberg; John Lynch; Daniel M Rosenbaum; Karen C Johnson; Howard D Strickler; Sylvia Wassertheil-Smoller
Journal:  J Stroke Cerebrovasc Dis       Date:  2008 Nov-Dec       Impact factor: 2.136

8.  Correlation between interleukin-6 promoter and C-reactive protein (CRP) polymorphisms and CRP levels with the Mainz Severity Score Index for Fabry disease.

Authors:  G Altarescu; G Chicco; C Whybra; S Delgado-Sanchez; N Sharon; M Beck; D Elstein
Journal:  J Inherit Metab Dis       Date:  2008-01-05       Impact factor: 4.982

9.  Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study.

Authors:  Myriam Fornage; Y Aron Chiang; Ellen S O'Meara; Bruce M Psaty; Alexander P Reiner; David S Siscovick; Russell P Tracy; W T Longstreth
Journal:  Stroke       Date:  2008-04-24       Impact factor: 7.914

Review 10.  Cerebral small vessel disease: genetic risk assessment for prevention and treatment.

Authors:  Ada Lam; M Anne Hamilton-Bruce; Jim Jannes; Simon A Koblar
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.